Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Genialis
Genialis Launches First-in-Class Biomarker to Predict Tumor Response and Clinical Benefit to KRAS Inhibitors
September 25, 2024
From
Genialis
Via
Business Wire
Pharma Oncology Development Veteran Krista McKerracher Named Chairperson of the Board for Genialis
June 12, 2024
From
Genialis
Via
Business Wire
Genialis and Pancreatic Cancer Action Network (PanCAN) Partner to Progress KRAS Diagnostics
May 31, 2024
From
Genialis
Via
Business Wire
New Genialis RNA Biomarker Accurately Predicts KRAS Outcomes in Lung Cancer Patients
April 09, 2024
From
Genialis
Via
Business Wire
Genialis and Debiopharm Set Up Biomarker Discovery Collaboration
January 25, 2024
From
Genialis
Via
Business Wire
Genialis Presents Data at SITC 2023 on RNA-Based Biomarkers to Predict Immunotherapy Response
November 03, 2023
From
Genialis
Via
Business Wire
Clinical Drug Discovery Veterans Join Genialis’ Efforts to Build Better Biomarkers for Precision Oncology
September 07, 2023
From
Genialis
Via
Business Wire
Genialis Unveils Expressions Version 3.0, Cloud Software for Faster, More Secure Data Processing and Management
May 08, 2023
From
Genialis
Via
Business Wire
Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response
March 29, 2023
From
Genialis
Via
Business Wire
Genialis Presents New Clinical Biomarker Findings at SITC, BioTechX
November 08, 2022
From
Genialis
Via
Business Wire
Genialis Updates ResponderID, Enhancing Data Flywheel for Improved Clinical Biomarker Discovery
September 29, 2022
From
Genialis
Via
Business Wire
Genialis Releases Improved Version of Expressions for Faster, More Secure Multi-Omics Processing and Data Management
April 20, 2022
From
Genialis
Via
Business Wire
Genialis ResponderID to Use Xerna™ TME Panel to Improve Targeted Therapy Selection
April 04, 2022
From
Genialis
Via
Business Wire
Inhibrx Selects Genialis ResponderID™ for Clinical Optimization Study of INBRX-109
February 28, 2022
From
Genialis
Via
Business Wire
Genialis Debuts ResponderID for Clinical Biomarker Discovery
November 02, 2021
From
Genialis
Via
Business Wire
Genialis Innovates Machine Learning Solutions for Clinical Biomarker Discovery
October 14, 2021
From
Genialis
Via
Business Wire
Genialis Expands Support for Clinical Biomarker Discovery Platform
June 10, 2021
From
Genialis
Via
Business Wire
Genialis Presents Updated Results on AI-Enabled, RNA-Based Pan-Cancer Biomarker Platform at AACR
April 12, 2021
From
Genialis
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.